Beijing Strong Biotechnologies (SZSE:300406) Interest Expense : ¥-47 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Beijing Strong Biotechnologies's interest expense for the three months ended in Mar. 2024 was ¥ -12 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-47 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Beijing Strong Biotechnologies's Operating Income for the three months ended in Mar. 2024 was ¥ 154 Mil. Beijing Strong Biotechnologies's Interest Expense for the three months ended in Mar. 2024 was ¥ -12 Mil. Beijing Strong Biotechnologies's Interest Coverage for the quarter that ended in Mar. 2024 was 13.06. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Beijing Strong Biotechnologies Interest Expense Historical Data

The historical data trend for Beijing Strong Biotechnologies's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies Interest Expense Chart

Beijing Strong Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1.24

-8.16

-21.59

-52.64

-46.99

Beijing Strong Biotechnologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-11.59	-11.93	-11.68	-11.80	-11.80

Beijing Strong Biotechnologies Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-47 Mil.

Beijing Strong Biotechnologies (SZSE:300406) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Beijing Strong Biotechnologies's Interest Expense for the three months ended in Mar. 2024 was ¥-12 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥154 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥1,164 Mil.

Beijing Strong Biotechnologies's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	154.125	/	-11.797
	=	13.06

The higher the ratio, the stronger the company's financial strength is.

Beijing Strong Biotechnologies (SZSE:300406) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191

Website

http://www.bsbe.com.cn

Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.

Executives

Shuang He	Executives
Luo Ai Ping	Director
	Directors, executives
Liu Wei	Executives
Zhou Ming	Executives
Zhuang Xian Min	Directors, executives
Zhang Yi	Executives
Liu Xi	Directors, executives
Sun Xiao Lin	Director
Yu Jian Ping	Executives

Beijing Strong Biotechnologies (SZSE:300406) Headlines

No Headlines